Global Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Regional Outlook and Forecast, 2024

List of Tables

The Global Genomics In Cancer Care Market size is expected to reach $53.5 billion by 2031, rising at a market growth of 15.7% CAGR during the forecast period.

High-throughput capabilities are provided by microarrays, which allow for the simultaneous analysis of thousands of transcripts in a single experiment. This extensive data collection is crucial for understanding cancer's complex genetic and molecular landscapes, leading to increased demand for microarray technologies in research and clinical applications. Microarrays enable comprehensive gene expression profiling, which helps identify differentially expressed cancer-associated genes. By providing a broad overview of gene activity, microarrays support discovering biomarkers, elucidating cancer mechanisms, and developing new therapeutic targets. Thus, the microarrays segment held 21% revenue share in the genomics in cancer care market.

The major strategies followed by the market participants are Acquisition as the key developmental strategy to keep pace with the changing demands of end users. For instance, In 2023, January, Agilent Technologies acquired Avida Biomed, a cancer care solutions provider. The acquisition enhances its SureSelect portfolio with advanced target enrichment workflows for next-generation sequencing. Additionally, In 2021, June, PerkinElmer, now known as Revvity, Inc., took over Sirion Biotech, a German biotech company. The acquisition enhances Perkinelmer's cell and gene therapy offerings.

Based on the Analysis presented in the KBV Cardinal matrix; F. Hoffmann-La Roche Ltd. is the forerunners in the Genomics In Cancer Care Market. Companies such as Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), GE HealthCare Technologies, Inc. are some of the key innovators in Genomics In Cancer Care Market.

COVID-19 Impact Analysis

Budget cuts and reallocating funds towards COVID-19 response efforts resulted in reduced investment in genomic research and development. Many clinical trials for genomic-based cancer therapies were paused or delayed during the pandemic. Recruitment of participants was hindered, and trial timelines were extended, affecting the development and availability of new genomic treatments. Thus, the COVID-19 pandemic had a negative impact on the market.

Market Growth Factors

A better grasp of cancer genomics allows for developing personalized medicine approaches. By analyzing a patient's unique genetic makeup, healthcare providers can tailor treatment plans specifically to the individual's cancer type and genetic profile. This personalized approach improves treatment efficacy and minimizes adverse effects, leading to a growing demand for genomic-based treatments.

Additionally, the increased focus on genomic research drives market growth by fostering the development of new genomic technologies and therapies. Thus, the rise in cancer incidence and prevalence is driving the growth of the market.

Market Restraining Factors

High costs of genomic testing can exacerbate disparities in healthcare access, particularly in low- and middle-income regions or among underserved populations. These disparities can result in unequal access to advanced genomic technologies and personalized treatments, affecting the overall market growth and hindering equitable cancer care. Hence, the high costs of genomic testing impede the market's growth.

Application Outlook

On the basis of application, the market is segmented into diagnostics, personalized medicine, drug discovery & development, and research. The diagnostics segment recorded 39% revenue share in the genomics in cancer care market in 2023. Genomic diagnostics are crucial in early detection and accurate cancer diagnosis.

Product Outlook

Based on product, the market is divided into instruments, consumables, and services. The services segment attained 21% revenue share in the genomics in cancer care market in 2023. As genomic technologies advance, the complexity of analyzing and interpreting genomic data increases.

Technology Outlook

By technology, the market is divided into genome sequencing, PCR, microarrays, nuclei acid extraction and purification, and others. In 2023, the PCR segment registered 32% revenue share in the genomics in cancer care market. PCR is known for its high sensitivity and specificity, which are crucial for accurately detecting and quantifying cancer-related genetic material.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 26% revenue share in the genomics in cancer care market. The Asia-Pacific region is experiencing a rising incidence of cancer due to factors such as population growth, aging demographics, and changes in lifestyle and environmental exposures.

Market Competition and Attributes

The Genomics in Cancer Care market is fiercely competitive, driven by rapid technological advancements and the increasing demand for personalized medicine. Key attributes include innovative genomic testing techniques, comprehensive data analytics capabilities, and robust bioinformatics solutions. Companies strive to differentiate through superior accuracy in cancer diagnostics, treatment selection, and monitoring. Market leaders focus on integrating multi-omic data to enhance therapeutic outcomes, while regulatory compliance and data privacy remain critical concerns.

Recent Strategies Deployed in the Market

Aug-2024: Beckman Coulter Life Sciences released the Illumina TruSight Oncology 500 DNA/RNA assa, an automated solution for oncology research on the Biomek NGeniuS System. This tool accelerates genomic profiling of tumor samples, handling up to 24 libraries per batch with reduced costs and faster results.
Apr-2024: Bio-Rad Laboratories partnered with Allegheny Health Network to research the use of Bio-Rad's Droplet Digital PCR (ddPCR) technology for monitoring molecular residual disease (MRD) in solid tumors. This partnership would enhance sensitivity and precision in detecting MRD, potentially improving patient outcomes through earlier and more accurate monitoring.
Apr-2024: Bio-Rad Laboratories released the ddPLEX ESR1 Mutation Detection Kit, a highly sensitive multiplexed digital PCR assay for detecting seven ESR1 mutations with 0.01% sensitivity. Compatible with the QX600 System, it provides rapid, simultaneous results from ctDNA or FFPE samples, enhancing oncology research and patient monitoring.
Oc-2023: F. Hoffmann-La Roche Ltd teamed up with AWS, a cloud computing company, to integrate AI-powered tools into its navify Digital Pathology platform. This partnership enhanced breast and prostate cancer diagnosis by improving accuracy, efficiency, and turnaround time in pathology labs, leveraging cloud infrastructure for scalability and security.

List of Key Companies Profiled

Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation (Beckman Coulter, Inc.)
Abbott Laboratories
Bio-Rad Laboratories, Inc.
GE HealthCare Technologies, Inc.
Quest Diagnostics Incorporated
Revvity, Inc.
Eurofins Scientific SE
Hologic, Inc.

Global Genomics In Cancer Care Market Report Segmentation

By Application

Diagnostics
Personalized Medicine
Drug Discovery & Development
Research

By Product

Instruments
Consumables
Services

By Technology

PCR
Genome Sequencing
Microarrays
Nuclei Acid Extraction & Purification
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Genomics In Cancer Care Market, by Application
- 1.4.2 Global Genomics In Cancer Care Market, by Product
- 1.4.3 Global Genomics In Cancer Care Market, by Technology
- 1.4.4 Global Genomics In Cancer Care Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan - 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. Global Genomics In Cancer Care Market by Application

5.1 Global Diagnostics Market by Region
5.2 Global Personalized Medicine Market by Region
5.3 Global Drug Discovery & Development Market by Region
5.4 Global Research Market by Region

Chapter 6. Global Genomics In Cancer Care Market by Product

6.1 Global Instruments Market by Region
6.2 Global Consumables Market by Region
6.3 Global Services Market by Region

Chapter 7. Global Genomics In Cancer Care Market by Technology

7.1 Global PCR Market by Region
7.2 Global Genome Sequencing Market by Region
7.3 Global Microarrays Market by Region
7.4 Global Nuclei Acid Extraction & Purification Market by Region
7.5 Global Others Market by Region

Chapter 8. Global Genomics In Cancer Care Market by Region

8.1 North America Genomics In Cancer Care Market
- 8.1.1 North America Genomics In Cancer Care Market by Application
  - 8.1.1.1 North America Diagnostics Market by Country
  - 8.1.1.2 North America Personalized Medicine Market by Country
  - 8.1.1.3 North America Drug Discovery & Development Market by Country
  - 8.1.1.4 North America Research Market by Country
- 8.1.2 North America Genomics In Cancer Care Market by Product
  - 8.1.2.1 North America Instruments Market by Country
  - 8.1.2.2 North America Consumables Market by Country
  - 8.1.2.3 North America Services Market by Country
- 8.1.3 North America Genomics In Cancer Care Market by Technology
  - 8.1.3.1 North America PCR Market by Country
  - 8.1.3.2 North America Genome Sequencing Market by Country
  - 8.1.3.3 North America Microarrays Market by Country
  - 8.1.3.4 North America Nuclei Acid Extraction & Purification Market by Country
  - 8.1.3.5 North America Others Market by Country
- 8.1.4 North America Genomics In Cancer Care Market by Country
  - 8.1.4.1 US Genomics In Cancer Care Market
    - 8.1.4.1.1 US Genomics In Cancer Care Market by Application
    - 8.1.4.1.2 US Genomics In Cancer Care Market by Product
    - 8.1.4.1.3 US Genomics In Cancer Care Market by Technology
  - 8.1.4.2 Canada Genomics In Cancer Care Market
    - 8.1.4.2.1 Canada Genomics In Cancer Care Market by Application
    - 8.1.4.2.2 Canada Genomics In Cancer Care Market by Product
    - 8.1.4.2.3 Canada Genomics In Cancer Care Market by Technology
  - 8.1.4.3 Mexico Genomics In Cancer Care Market
    - 8.1.4.3.1 Mexico Genomics In Cancer Care Market by Application
    - 8.1.4.3.2 Mexico Genomics In Cancer Care Market by Product
    - 8.1.4.3.3 Mexico Genomics In Cancer Care Market by Technology
  - 8.1.4.4 Rest of North America Genomics In Cancer Care Market
    - 8.1.4.4.1 Rest of North America Genomics In Cancer Care Market by Application
    - 8.1.4.4.2 Rest of North America Genomics In Cancer Care Market by Product
    - 8.1.4.4.3 Rest of North America Genomics In Cancer Care Market by Technology
8.2 Europe Genomics In Cancer Care Market
- 8.2.1 Europe Genomics In Cancer Care Market by Application
  - 8.2.1.1 Europe Diagnostics Market by Country
  - 8.2.1.2 Europe Personalized Medicine Market by Country
  - 8.2.1.3 Europe Drug Discovery & Development Market by Country
  - 8.2.1.4 Europe Research Market by Country
- 8.2.2 Europe Genomics In Cancer Care Market by Product
  - 8.2.2.1 Europe Instruments Market by Country
  - 8.2.2.2 Europe Consumables Market by Country
  - 8.2.2.3 Europe Services Market by Country
- 8.2.3 Europe Genomics In Cancer Care Market by Technology
  - 8.2.3.1 Europe PCR Market by Country
  - 8.2.3.2 Europe Genome Sequencing Market by Country
  - 8.2.3.3 Europe Microarrays Market by Country
  - 8.2.3.4 Europe Nuclei Acid Extraction & Purification Market by Country
  - 8.2.3.5 Europe Others Market by Country
- 8.2.4 Europe Genomics In Cancer Care Market by Country
  - 8.2.4.1 Germany Genomics In Cancer Care Market
    - 8.2.4.1.1 Germany Genomics In Cancer Care Market by Application
    - 8.2.4.1.2 Germany Genomics In Cancer Care Market by Product
    - 8.2.4.1.3 Germany Genomics In Cancer Care Market by Technology
  - 8.2.4.2 UK Genomics In Cancer Care Market
    - 8.2.4.2.1 UK Genomics In Cancer Care Market by Application
    - 8.2.4.2.2 UK Genomics In Cancer Care Market by Product
    - 8.2.4.2.3 UK Genomics In Cancer Care Market by Technology
  - 8.2.4.3 France Genomics In Cancer Care Market
    - 8.2.4.3.1 France Genomics In Cancer Care Market by Application
    - 8.2.4.3.2 France Genomics In Cancer Care Market by Product
    - 8.2.4.3.3 France Genomics In Cancer Care Market by Technology
  - 8.2.4.4 Russia Genomics In Cancer Care Market
    - 8.2.4.4.1 Russia Genomics In Cancer Care Market by Application
    - 8.2.4.4.2 Russia Genomics In Cancer Care Market by Product
    - 8.2.4.4.3 Russia Genomics In Cancer Care Market by Technology
  - 8.2.4.5 Spain Genomics In Cancer Care Market
    - 8.2.4.5.1 Spain Genomics In Cancer Care Market by Application
    - 8.2.4.5.2 Spain Genomics In Cancer Care Market by Product
    - 8.2.4.5.3 Spain Genomics In Cancer Care Market by Technology
  - 8.2.4.6 Italy Genomics In Cancer Care Market
    - 8.2.4.6.1 Italy Genomics In Cancer Care Market by Application
    - 8.2.4.6.2 Italy Genomics In Cancer Care Market by Product
    - 8.2.4.6.3 Italy Genomics In Cancer Care Market by Technology
  - 8.2.4.7 Rest of Europe Genomics In Cancer Care Market
    - 8.2.4.7.1 Rest of Europe Genomics In Cancer Care Market by Application
    - 8.2.4.7.2 Rest of Europe Genomics In Cancer Care Market by Product
    - 8.2.4.7.3 Rest of Europe Genomics In Cancer Care Market by Technology
8.3 Asia Pacific Genomics In Cancer Care Market
- 8.3.1 Asia Pacific Genomics In Cancer Care Market by Application
  - 8.3.1.1 Asia Pacific Diagnostics Market by Country
  - 8.3.1.2 Asia Pacific Personalized Medicine Market by Country
  - 8.3.1.3 Asia Pacific Drug Discovery & Development Market by Country
  - 8.3.1.4 Asia Pacific Research Market by Country
- 8.3.2 Asia Pacific Genomics In Cancer Care Market by Product
  - 8.3.2.1 Asia Pacific Instruments Market by Country
  - 8.3.2.2 Asia Pacific Consumables Market by Country
  - 8.3.2.3 Asia Pacific Services Market by Country
- 8.3.3 Asia Pacific Genomics In Cancer Care Market by Technology
  - 8.3.3.1 Asia Pacific PCR Market by Country
  - 8.3.3.2 Asia Pacific Genome Sequencing Market by Country
  - 8.3.3.3 Asia Pacific Microarrays Market by Country
  - 8.3.3.4 Asia Pacific Nuclei Acid Extraction & Purification Market by Country
  - 8.3.3.5 Asia Pacific Others Market by Country
- 8.3.4 Asia Pacific Genomics In Cancer Care Market by Country
  - 8.3.4.1 China Genomics In Cancer Care Market
    - 8.3.4.1.1 China Genomics In Cancer Care Market by Application
    - 8.3.4.1.2 China Genomics In Cancer Care Market by Product
    - 8.3.4.1.3 China Genomics In Cancer Care Market by Technology
  - 8.3.4.2 Japan Genomics In Cancer Care Market
    - 8.3.4.2.1 Japan Genomics In Cancer Care Market by Application
    - 8.3.4.2.2 Japan Genomics In Cancer Care Market by Product
    - 8.3.4.2.3 Japan Genomics In Cancer Care Market by Technology
  - 8.3.4.3 India Genomics In Cancer Care Market
    - 8.3.4.3.1 India Genomics In Cancer Care Market by Application
    - 8.3.4.3.2 India Genomics In Cancer Care Market by Product
    - 8.3.4.3.3 India Genomics In Cancer Care Market by Technology
  - 8.3.4.4 South Korea Genomics In Cancer Care Market
    - 8.3.4.4.1 South Korea Genomics In Cancer Care Market by Application
    - 8.3.4.4.2 South Korea Genomics In Cancer Care Market by Product
    - 8.3.4.4.3 South Korea Genomics In Cancer Care Market by Technology
  - 8.3.4.5 Singapore Genomics In Cancer Care Market
    - 8.3.4.5.1 Singapore Genomics In Cancer Care Market by Application
    - 8.3.4.5.2 Singapore Genomics In Cancer Care Market by Product
    - 8.3.4.5.3 Singapore Genomics In Cancer Care Market by Technology
  - 8.3.4.6 Malaysia Genomics In Cancer Care Market
    - 8.3.4.6.1 Malaysia Genomics In Cancer Care Market by Application
    - 8.3.4.6.2 Malaysia Genomics In Cancer Care Market by Product
    - 8.3.4.6.3 Malaysia Genomics In Cancer Care Market by Technology
  - 8.3.4.7 Rest of Asia Pacific Genomics In Cancer Care Market
    - 8.3.4.7.1 Rest of Asia Pacific Genomics In Cancer Care Market by Application
    - 8.3.4.7.2 Rest of Asia Pacific Genomics In Cancer Care Market by Product
    - 8.3.4.7.3 Rest of Asia Pacific Genomics In Cancer Care Market by Technology
8.4 LAMEA Genomics In Cancer Care Market
- 8.4.1 LAMEA Genomics In Cancer Care Market by Application
  - 8.4.1.1 LAMEA Diagnostics Market by Country
  - 8.4.1.2 LAMEA Personalized Medicine Market by Country
  - 8.4.1.3 LAMEA Drug Discovery & Development Market by Country
  - 8.4.1.4 LAMEA Research Market by Country
- 8.4.2 LAMEA Genomics In Cancer Care Market by Product
  - 8.4.2.1 LAMEA Instruments Market by Country
  - 8.4.2.2 LAMEA Consumables Market by Country
  - 8.4.2.3 LAMEA Services Market by Country
- 8.4.3 LAMEA Genomics In Cancer Care Market by Technology
  - 8.4.3.1 LAMEA PCR Market by Country
  - 8.4.3.2 LAMEA Genome Sequencing Market by Country
  - 8.4.3.3 LAMEA Microarrays Market by Country
  - 8.4.3.4 LAMEA Nuclei Acid Extraction & Purification Market by Country
  - 8.4.3.5 LAMEA Others Market by Country
- 8.4.4 LAMEA Genomics In Cancer Care Market by Country
  - 8.4.4.1 Brazil Genomics In Cancer Care Market
    - 8.4.4.1.1 Brazil Genomics In Cancer Care Market by Application
    - 8.4.4.1.2 Brazil Genomics In Cancer Care Market by Product
    - 8.4.4.1.3 Brazil Genomics In Cancer Care Market by Technology
  - 8.4.4.2 Argentina Genomics In Cancer Care Market
    - 8.4.4.2.1 Argentina Genomics In Cancer Care Market by Application
    - 8.4.4.2.2 Argentina Genomics In Cancer Care Market by Product
    - 8.4.4.2.3 Argentina Genomics In Cancer Care Market by Technology
  - 8.4.4.3 UAE Genomics In Cancer Care Market
    - 8.4.4.3.1 UAE Genomics In Cancer Care Market by Application
    - 8.4.4.3.2 UAE Genomics In Cancer Care Market by Product
    - 8.4.4.3.3 UAE Genomics In Cancer Care Market by Technology
  - 8.4.4.4 Saudi Arabia Genomics In Cancer Care Market
    - 8.4.4.4.1 Saudi Arabia Genomics In Cancer Care Market by Application
    - 8.4.4.4.2 Saudi Arabia Genomics In Cancer Care Market by Product
    - 8.4.4.4.3 Saudi Arabia Genomics In Cancer Care Market by Technology
  - 8.4.4.5 South Africa Genomics In Cancer Care Market
    - 8.4.4.5.1 South Africa Genomics In Cancer Care Market by Application
    - 8.4.4.5.2 South Africa Genomics In Cancer Care Market by Product
    - 8.4.4.5.3 South Africa Genomics In Cancer Care Market by Technology
  - 8.4.4.6 Nigeria Genomics In Cancer Care Market
    - 8.4.4.6.1 Nigeria Genomics In Cancer Care Market by Application
    - 8.4.4.6.2 Nigeria Genomics In Cancer Care Market by Product
    - 8.4.4.6.3 Nigeria Genomics In Cancer Care Market by Technology
  - 8.4.4.7 Rest of LAMEA Genomics In Cancer Care Market
    - 8.4.4.7.1 Rest of LAMEA Genomics In Cancer Care Market by Application
    - 8.4.4.7.2 Rest of LAMEA Genomics In Cancer Care Market by Product
    - 8.4.4.7.3 Rest of LAMEA Genomics In Cancer Care Market by Technology

Chapter 9. Company Profiles

9.1 Agilent Technologies, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Partnerships, Collaborations, and Agreements:
  - 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.6 SWOT Analysis
9.4 Abbott Laboratories
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
  - 9.5.5.1 Partnerships, Collaborations, and Agreements:
  - 9.5.5.2 Product Launches and Product Expansions:
- 9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental Analysis
- 9.7.4 SWOT Analysis
9.8 Revvity, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
  - 9.8.5.1 Acquisition and Mergers:
- 9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 SWOT Analysis
9.10. Hologic, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 Recent strategies and developments:
  - 9.10.5.1 Acquisition and Mergers:
- 9.10.6 SWOT Analysis

Chapter 10. Winning Imperatives for Genomics In Cancer Care Market

LIST OF TABLES

TABLE 1 Global Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 2 Global Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Genomics In Cancer Care Market
TABLE 4 Product Launches And Product Expansions- Genomics In Cancer Care Market
TABLE 5 Acquisition and Mergers- Genomics In Cancer Care Market
TABLE 6 Global Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 7 Global Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 8 Global Diagnostics Market by Region, 2020 - 2023, USD Million
TABLE 9 Global Diagnostics Market by Region, 2024 - 2031, USD Million
TABLE 10 Global Personalized Medicine Market by Region, 2020 - 2023, USD Million
TABLE 11 Global Personalized Medicine Market by Region, 2024 - 2031, USD Million
TABLE 12 Global Drug Discovery & Development Market by Region, 2020 - 2023, USD Million
TABLE 13 Global Drug Discovery & Development Market by Region, 2024 - 2031, USD Million
TABLE 14 Global Research Market by Region, 2020 - 2023, USD Million
TABLE 15 Global Research Market by Region, 2024 - 2031, USD Million
TABLE 16 Global Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 17 Global Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 18 Global Instruments Market by Region, 2020 - 2023, USD Million
TABLE 19 Global Instruments Market by Region, 2024 - 2031, USD Million
TABLE 20 Global Consumables Market by Region, 2020 - 2023, USD Million
TABLE 21 Global Consumables Market by Region, 2024 - 2031, USD Million
TABLE 22 Global Services Market by Region, 2020 - 2023, USD Million
TABLE 23 Global Services Market by Region, 2024 - 2031, USD Million
TABLE 24 Global Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 25 Global Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 26 Global PCR Market by Region, 2020 - 2023, USD Million
TABLE 27 Global PCR Market by Region, 2024 - 2031, USD Million
TABLE 28 Global Genome Sequencing Market by Region, 2020 - 2023, USD Million
TABLE 29 Global Genome Sequencing Market by Region, 2024 - 2031, USD Million
TABLE 30 Global Microarrays Market by Region, 2020 - 2023, USD Million
TABLE 31 Global Microarrays Market by Region, 2024 - 2031, USD Million
TABLE 32 Global Nuclei Acid Extraction & Purification Market by Region, 2020 - 2023, USD Million
TABLE 33 Global Nuclei Acid Extraction & Purification Market by Region, 2024 - 2031, USD Million
TABLE 34 Global Others Market by Region, 2020 - 2023, USD Million
TABLE 35 Global Others Market by Region, 2024 - 2031, USD Million
TABLE 36 Global Genomics In Cancer Care Market by Region, 2020 - 2023, USD Million
TABLE 37 Global Genomics In Cancer Care Market by Region, 2024 - 2031, USD Million
TABLE 38 North America Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 39 North America Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 40 North America Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 41 North America Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 42 North America Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 43 North America Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 44 North America Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 45 North America Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 46 North America Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 47 North America Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 48 North America Research Market by Country, 2020 - 2023, USD Million
TABLE 49 North America Research Market by Country, 2024 - 2031, USD Million
TABLE 50 North America Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 51 North America Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 52 North America Instruments Market by Country, 2020 - 2023, USD Million
TABLE 53 North America Instruments Market by Country, 2024 - 2031, USD Million
TABLE 54 North America Consumables Market by Country, 2020 - 2023, USD Million
TABLE 55 North America Consumables Market by Country, 2024 - 2031, USD Million
TABLE 56 North America Services Market by Country, 2020 - 2023, USD Million
TABLE 57 North America Services Market by Country, 2024 - 2031, USD Million
TABLE 58 North America Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 59 North America Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 60 North America PCR Market by Country, 2020 - 2023, USD Million
TABLE 61 North America PCR Market by Country, 2024 - 2031, USD Million
TABLE 62 North America Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 63 North America Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 64 North America Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 65 North America Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 66 North America Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 67 North America Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 68 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 69 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 70 North America Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 71 North America Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 72 US Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 73 US Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 74 US Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 75 US Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 76 US Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 77 US Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 78 US Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 79 US Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 80 Canada Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 81 Canada Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 82 Canada Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 83 Canada Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 84 Canada Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 85 Canada Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 86 Canada Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 87 Canada Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 88 Mexico Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 89 Mexico Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 90 Mexico Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 91 Mexico Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 92 Mexico Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 93 Mexico Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 94 Mexico Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 95 Mexico Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 96 Rest of North America Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 97 Rest of North America Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 98 Rest of North America Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 99 Rest of North America Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 100 Rest of North America Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 101 Rest of North America Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 102 Rest of North America Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 103 Rest of North America Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 104 Europe Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 105 Europe Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 106 Europe Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 107 Europe Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 108 Europe Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 109 Europe Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 110 Europe Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 111 Europe Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 112 Europe Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 113 Europe Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 114 Europe Research Market by Country, 2020 - 2023, USD Million
TABLE 115 Europe Research Market by Country, 2024 - 2031, USD Million
TABLE 116 Europe Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 117 Europe Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 118 Europe Instruments Market by Country, 2020 - 2023, USD Million
TABLE 119 Europe Instruments Market by Country, 2024 - 2031, USD Million
TABLE 120 Europe Consumables Market by Country, 2020 - 2023, USD Million
TABLE 121 Europe Consumables Market by Country, 2024 - 2031, USD Million
TABLE 122 Europe Services Market by Country, 2020 - 2023, USD Million
TABLE 123 Europe Services Market by Country, 2024 - 2031, USD Million
TABLE 124 Europe Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 125 Europe Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 126 Europe PCR Market by Country, 2020 - 2023, USD Million
TABLE 127 Europe PCR Market by Country, 2024 - 2031, USD Million
TABLE 128 Europe Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 129 Europe Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 130 Europe Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 131 Europe Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 132 Europe Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 133 Europe Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 134 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 135 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 136 Europe Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 137 Europe Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 138 Germany Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 139 Germany Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 140 Germany Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 141 Germany Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 142 Germany Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 143 Germany Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 144 Germany Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 145 Germany Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 146 UK Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 147 UK Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 148 UK Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 149 UK Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 150 UK Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 151 UK Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 152 UK Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 153 UK Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 154 France Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 155 France Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 156 France Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 157 France Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 158 France Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 159 France Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 160 France Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 161 France Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 162 Russia Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 163 Russia Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 164 Russia Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 165 Russia Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 166 Russia Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 167 Russia Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 168 Russia Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 169 Russia Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 170 Spain Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 171 Spain Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 172 Spain Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 173 Spain Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 174 Spain Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 175 Spain Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 176 Spain Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 177 Spain Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 178 Italy Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 179 Italy Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 180 Italy Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 181 Italy Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 182 Italy Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 183 Italy Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 184 Italy Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 185 Italy Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 186 Rest of Europe Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 187 Rest of Europe Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 188 Rest of Europe Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 189 Rest of Europe Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 190 Rest of Europe Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 191 Rest of Europe Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 192 Rest of Europe Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 193 Rest of Europe Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 194 Asia Pacific Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 195 Asia Pacific Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 196 Asia Pacific Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 197 Asia Pacific Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 198 Asia Pacific Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 199 Asia Pacific Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 200 Asia Pacific Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 201 Asia Pacific Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 202 Asia Pacific Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 203 Asia Pacific Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 204 Asia Pacific Research Market by Country, 2020 - 2023, USD Million
TABLE 205 Asia Pacific Research Market by Country, 2024 - 2031, USD Million
TABLE 206 Asia Pacific Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 207 Asia Pacific Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 208 Asia Pacific Instruments Market by Country, 2020 - 2023, USD Million
TABLE 209 Asia Pacific Instruments Market by Country, 2024 - 2031, USD Million
TABLE 210 Asia Pacific Consumables Market by Country, 2020 - 2023, USD Million
TABLE 211 Asia Pacific Consumables Market by Country, 2024 - 2031, USD Million
TABLE 212 Asia Pacific Services Market by Country, 2020 - 2023, USD Million
TABLE 213 Asia Pacific Services Market by Country, 2024 - 2031, USD Million
TABLE 214 Asia Pacific Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 215 Asia Pacific Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 216 Asia Pacific PCR Market by Country, 2020 - 2023, USD Million
TABLE 217 Asia Pacific PCR Market by Country, 2024 - 2031, USD Million
TABLE 218 Asia Pacific Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 219 Asia Pacific Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 220 Asia Pacific Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 221 Asia Pacific Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 222 Asia Pacific Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 223 Asia Pacific Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 224 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 225 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 226 Asia Pacific Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 227 Asia Pacific Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 228 China Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 229 China Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 230 China Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 231 China Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 232 China Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 233 China Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 234 China Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 235 China Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 236 Japan Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 237 Japan Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 238 Japan Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 239 Japan Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 240 Japan Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 241 Japan Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 242 Japan Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 243 Japan Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 244 India Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 245 India Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 246 India Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 247 India Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 248 India Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 249 India Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 250 India Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 251 India Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 252 South Korea Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 253 South Korea Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 254 South Korea Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 255 South Korea Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 256 South Korea Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 257 South Korea Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 258 South Korea Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 259 South Korea Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 260 Singapore Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 261 Singapore Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 262 Singapore Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 263 Singapore Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 264 Singapore Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 265 Singapore Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 266 Singapore Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 267 Singapore Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 268 Malaysia Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 269 Malaysia Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 270 Malaysia Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 271 Malaysia Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 272 Malaysia Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 273 Malaysia Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 274 Malaysia Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 275 Malaysia Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 276 Rest of Asia Pacific Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 277 Rest of Asia Pacific Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 278 Rest of Asia Pacific Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 279 Rest of Asia Pacific Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 280 Rest of Asia Pacific Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 281 Rest of Asia Pacific Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 282 Rest of Asia Pacific Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 283 Rest of Asia Pacific Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 284 LAMEA Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 285 LAMEA Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 286 LAMEA Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 287 LAMEA Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 288 LAMEA Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 289 LAMEA Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 290 LAMEA Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 291 LAMEA Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 292 LAMEA Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 293 LAMEA Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 294 LAMEA Research Market by Country, 2020 - 2023, USD Million
TABLE 295 LAMEA Research Market by Country, 2024 - 2031, USD Million
TABLE 296 LAMEA Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 297 LAMEA Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 298 LAMEA Instruments Market by Country, 2020 - 2023, USD Million
TABLE 299 LAMEA Instruments Market by Country, 2024 - 2031, USD Million
TABLE 300 LAMEA Consumables Market by Country, 2020 - 2023, USD Million
TABLE 301 LAMEA Consumables Market by Country, 2024 - 2031, USD Million
TABLE 302 LAMEA Services Market by Country, 2020 - 2023, USD Million
TABLE 303 LAMEA Services Market by Country, 2024 - 2031, USD Million
TABLE 304 LAMEA Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 305 LAMEA Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 306 LAMEA PCR Market by Country, 2020 - 2023, USD Million
TABLE 307 LAMEA PCR Market by Country, 2024 - 2031, USD Million
TABLE 308 LAMEA Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 309 LAMEA Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 310 LAMEA Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 311 LAMEA Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 312 LAMEA Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 313 LAMEA Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 314 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 315 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 316 LAMEA Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 317 LAMEA Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 318 Brazil Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 319 Brazil Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 320 Brazil Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 321 Brazil Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 322 Brazil Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 323 Brazil Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 324 Brazil Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 325 Brazil Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 326 Argentina Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 327 Argentina Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 328 Argentina Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 329 Argentina Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 330 Argentina Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 331 Argentina Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 332 Argentina Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 333 Argentina Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 334 UAE Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 335 UAE Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 336 UAE Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 337 UAE Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 338 UAE Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 339 UAE Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 340 UAE Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 341 UAE Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 342 Saudi Arabia Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 343 Saudi Arabia Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 344 Saudi Arabia Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 345 Saudi Arabia Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 346 Saudi Arabia Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 347 Saudi Arabia Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 348 Saudi Arabia Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 349 Saudi Arabia Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 350 South Africa Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 351 South Africa Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 352 South Africa Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 353 South Africa Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 354 South Africa Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 355 South Africa Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 356 South Africa Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 357 South Africa Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 358 Nigeria Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 359 Nigeria Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 360 Nigeria Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 361 Nigeria Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 362 Nigeria Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 363 Nigeria Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 364 Nigeria Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 365 Nigeria Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 366 Rest of LAMEA Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 367 Rest of LAMEA Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 368 Rest of LAMEA Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 369 Rest of LAMEA Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 370 Rest of LAMEA Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 371 Rest of LAMEA Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 372 Rest of LAMEA Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 373 Rest of LAMEA Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 374 key Information - Agilent Technologies, Inc.
TABLE 375 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 376 Key Information - Danaher Corporation
TABLE 377 Key Information - Abbott Laboratories
TABLE 378 Key Information - Bio-Rad Laboratories, Inc.
TABLE 379 Key Information - GE HealthCare Technologies, Inc.
TABLE 380 Key information - Quest Diagnostics Incorporated
TABLE 381 Key Information - Revvity, Inc.
TABLE 382 Key Information - Eurofins Scientific SE
TABLE 383 Key Information - Hologic, Inc.

Global Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Regional Outlook and Forecast, 2024 - 2031

Description

Table of Contents